US3800792A - Laminated collagen film dressing - Google Patents

Laminated collagen film dressing Download PDF

Info

Publication number
US3800792A
US3800792A US3800792DA US3800792A US 3800792 A US3800792 A US 3800792A US 3800792D A US3800792D A US 3800792DA US 3800792 A US3800792 A US 3800792A
Authority
US
Grant status
Grant
Patent type
Prior art keywords
collagen
dressing
film
layer
compressed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
Inventor
Knight J Mc
J Guldalian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson
Original Assignee
Johnson and Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/425Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A61L15/325Collagen
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S128/00Surgery
    • Y10S128/08Collagen

Abstract

A surgical dressing that is particularly useful for the treatment of burn wounds is disclosed made from a thicker layer of a collagen compressed foam film to which has been laminated, without any adhesive, a thin continuous layer of an inert polymer material, such as polyurethane, having a moisture vapor transmission rate slightly higher than that of human skin and which preferably also contains finely divided silver metal impregnated in the collagen layer.

Description

LAMINATED COLLAGEN FILM DRESSING Inventors: James J. McKnight, Martinsville;

Jack Guldalian, Jr., Laurence Twp., Mercer County, both of NJ.

[73] Assignee: Johnson & Johnson, New

Brunswick, NJ.

[22] Filed: Apr. 17, 1972 [21] Appl. No.: 244,439

[52] U.S. Cl 128/156, l28/DIG. 8, 260/114 [51] Int. Cl A611 15/00 [58] Field of Search 128/156, 334, DIG. 8; 260/114; 264/28 [56] References Cited UNITED STATES PATENTS 3,491,760 l/l970 Braum et al. 128/334 2,194,677 3/1940 Schneiderwirth 260/14 3,471,598 10/1969 Battista 264/28 3,628,974 12/1971 Battista 128/156 3,113,568 12/1963 Robins 128/156 Primary Examiner-Richard A. Gaudet Assistant Examiner-J. Yasko Attorney, Agent, or Firm-Herbert l. Sherman [57 ABSTRACT A surgical dressing thatv is particularly useful for the treatment of burn wounds is disclosed made from a thicker layer of a collagen compressed foam film to which has been laminated, without any adhesive, a thin continuous layer of an inert polymer material,

, such as polyurethane, having a moisture vapor transmission rate slightly higher than that of human skin and which preferably also contains finely divided silver metal impregnated in the collagen layer.

7 Claims, 3 Drawing Figures LAMINATED COLLAGEN FILM DRESSING BACKGROUND AND SUMMARY OF THE INVENTION In the treatment of severe burn wounds, i.e. second and third degree burn wounds, the patient passes through a number of different treatment phases. The first phase is to clean and stabilize the wound area and control the bacterial flora at the wound site. This treatment is carried out by debridement of the wound site, maintaining an electrolyte balance and by the topical application of antibacterial medications such as silver nitrate, silver sulfadiazine and other similar medications. The wound then passes through development of a granulation bed. Once this phase of the treatment is under control, the status quo of the wound site must be maintained awaiting autografting to complete the treatment. Since in many cases a period of time will pass before autografting is possible, the maintenance of the status quo wound site, i.e. the granulation bed, is an absolute necessity. The present methods used to maintain the status quo are by the repeated applications of wet gauze dressings or by employing a temporary homograft or heterograft. The repeated application of wet dressings is not particularly satisfactory as these dressings require frequent changes within any 24-hour period and tend to add to the discomfort of the patient. Homografts and heterografts have been found to be effective, but they are not readily available.

An object of the present invention is therefore to develop a material which can be considered a substitute for a homograft or a heterograft and which will maintain the wound site, i.e. the granulation bed, in a status quo condition until an autograft becomes feasible.

The requirements for a substitute homograft or heterograft, which the dressing of the present invention meets, are the following:

1. It should be a readily available material.

2. It should be capable of being applied to the wound site so as to completely isolate the wound site from the environment.

3. It must have sufficient strength to be secured over the wound area by sutures, clips, gauze, or with adhesive bandages.

4. It must be capable of being sterilized and easily stored.

5. It must have no antigenic properties.

6. It must have a moisture vapor transmission rate which will allow the proper moisture balance in the repairing wound, i.e. to prevent both hydration and dessication of the repairing tissue.

Moisture vapor transmission rate is the weight of water lost by evaporation through a film membrane at 37C over a period of 24 hours. The weight loss is determined using a Twing Albert permeability cap in a Blue M Electric Company Model POM-203A forced air oven at 37C. The weight loss is observed periodically over a 24 to 48 hour period. This moisture vapor transmission rate figure will vary if measured by other possible procedures, and all rates described herein are those measured by the above method.

It was formerly thought that this rate should be similar to that of human skin, i.e. about 1-1.5 milligrams per hour per centimeter squared, but we have learned that the rate should be slightly higher, i.e. about 2-7 milligrams per hour per centimeter squared mglhrlcm We have developed a simple dressing that meets these requirements. Our dressing is composed of a thicker layer (that which will be placed on the skin in actual use) of reconstituted collagen formed into a compressed tanned collagen foam film to which is laminated a thinner outer layer of an inert polymer plastic material, preferably polyurethane. A greatly preferred embodiment contains finely divided silver impregnated and distributed through the collagen layer.

Our new dressing can be 3-30 mils thick and is preferably about 18 mils thick. The dressing of our invention can have a moisture vapor transmission rate of from 2 to 7 mg/hr/cm and preferably has a rate of 3 mg/hr/cm.

DISCUSSION OF PRIOR ART Collagen in various forms has been used together with various other materials in the treatment of wounds and of burns. Braun, US. Pat. No. 3,491,760, discloses a skin used in heterotransplantation which is made from two different tanned collagen gel layers. The material is used to produce a heteroplastic skin by acting as a suitable nutrient medium. The layer next to the skin has a large-celled, foamy consistency (but is not a compressed foam), and it is covered by a collagen film which is very tough, elastic, and almost leathery to prevent the drying out of the first film. The patent-teaches v the optional cementing of an adhering plastic film, such as polyvinylchloride foil, over the leathery collagen film to prevent drying out of the collagen gel. The heteroplastic skin thus formed is fairly thick (the collagen foamy layer being well over mils thick and much thicker than that which applicants use). The various layers are cemented together with adhesives. A collagen foil dressing product that appears to be made by this method has been sold in Germany. This prior art dressing appears to have a moisture vapor transmission rate different from that of the instant invention.

Battista US. Pat. No. 3,471,598 discloses freeze drying a dispersion of a microcrystalline collagen to form a mat, which can be used in various applications including surgical dressings.

British Pat. No. 1,195,062, entitled Structures Comprising Microcrystalline Collagen and Methods of Forming Them,'discloses the use of microcrystalline colloidal dispersions and gels to produce films, which may then be applied to coat various types of fibers including fibers of various organic polymers such as polyurethane.

Schulte, US. Pat. No. 2,202,566, discloses the use of collagen fibers in a bandage.

Robbins, US. Pat. No. 3,113,568, discloses the use of a polyurethane foam in a special type of bandage.

None of the art specificallydiscloses the concept of the present invention of dressing made from a particular type of collagen formed into a layer of compressed collagen foam having laminated thereto a polyurethane film which has a moisture vapor transmission slightly higher than that of skin.

Reference is now made to the drawings wherein are set forth by way of illustration and examples certain embodiments of the present invention.

Referring to the drawings:

FIG. 1 is a plan view of a microphotograph showing the top 10 (i.e. the part away from the skin in actual use) of the surgical dressing of the present invention taken at 3,000 times magnification, and it shows the outer surface of the thinner polyurethane layer 12, which contains a great many microscopic pores 14.

FIG. 2 is an inverted plan view of a microphotograph showing the bottom 20 (i.e. the part which goes next to the skin in actual use) of the surgical dressing of the present invention taken at 10,000 times magnification, and it shows the outer. surface of the thicker compressed collagen foam 22, which contains a network of collagen fibers or fibrils 24 with pores or open spaces 26 between the collagen fibers or'fibrils.

FIG. 3 is a diagrammatic cross-section view on line 3-3 from FIG. 1 showing a side view through the center of the surgical dressing of the present invention. It shows the polyurethane layer laminated to the compressed collagen foam layer 20. Also visible in FIG. 3 are the pores 14 in the polyurethane, the collagen fibers 24 and the open spaces 26 between the collagen fibers, and the particles of silver metal 28 impregnated in the collagen foam 20.

THE STARTING COLLAGEN The compressed collagen foam film used in the surgical dressing of the instant invention may be made from collagen obtained from various sources as long as it has the necessary properties hereinafter described. Bovine collagen is the most common source. In particular, we have found satisfactory results may be obtained from a commercial product which is marketed by FMC Corporation under the trademark Avitene" or very small, fine, fluffy, collagen fiber particles which are relatively soft and not degraded, made as described in US. Pat. No. 3,471,598 and other patents assigned to FMC Corporation. Other usable collagen fibers are those used in the gels from which collagen sausage casings are extruded, which have been ground or milled to the smaller, fine, fiuffy sizes used here. Bovine hide-dried, ground, or milled-can also be used to make the gel from which the compressed foam of the present invention is made.

PREPARATION OF COLLAGEN GEL The starting collagen is separated into very fine, fluffy fibers (dry to feel and touch) on the order of 25, 35, and 50 mesh size. Avitene is sold as a dry fibrous blend of finely divided collagen fibers. These are screened through various sized sieves to separate the collagen into fibers of the same relative size on the order of 25-50 mesh. While specific size and mixtures of size is not critical and smaller or larger pieces of collagen could be used, we prefer to use equal parts of several different sizes, e.g. of 25, 35, and 50 mesh, blended together. The collagen fibers are then made into an aqueous dispersion with water, which dispersion contains about 3.5 percent by weight of said collagen fibers. The dispersion is homogenized and allowed to stand. The time of standing is not critical, but we have found 1 hour to be satisfactory. Then a fast evaporating organic solvent such as petroleum ether is added to the amount of about percent by volume. The purpose of using the organic solvent is to prevent complete selfbonding of the fibers in the reconstituted product. When Avitene collagen is used, the petroleum ether is added to the initial aqueous dispersion. Where a dry collagen other than Avitene has been used, the resultant blend is then acid swollen in the well known fashion (we prefer to use 0.8 percent by weight of lactic acid, but other acids or amounts should work also) and allowed to stand. Where Avitene is used, this step is omitted since the material is already in the acid state. The fibers are swollen by the action of the lactic acid and take up the liquid present in the dispersion to form a gel. The gel is preferably permitted to stand long enough to attain equilibrium, e.g. for an hour, before being used in the next step of the process.

PREPARATION OF COLLAGEN FOAM FILM The above gel, which contains acid swollen collagen, is spread into a thick wet film on the order of about 25 to mils, preferably 50 mils thick. The thickness of this thick wet gel film can vary, of course, depending on the desired thickness of the collagen layer in the desired end product dressing. It is next desired to impart further porosity to the collagen film so it will be somewhat foamy and also to tan (i.e. to cross-link) the collagen. Various foaming agents and tanning agents could be used. We prefer to soak the wet film in a 5 percent sodium bicarbonate solution which also contains 400 parts per million or more glutaraldehyde for a period of 1 hour. The glutaraldehyde is the tanning agent. The sodium bicarbonate is used to control the porosity of the film since it introduces uniform size gas bubbles while the acid swollen film is being neutralized with bicarbonate ions.

The resultant porous collagen film which has now been neutralized with bicarbonate, has had its constituent collagen deswollen so it now has a lesser thickness about one-half its former swollen size. It is then dried, e.g. by air drying. The resultant dried porous collagen film is well rinsed with water. We prefer a rinsing time of 1 hour. The water-rinsed film is then plasticized slightly. A suitable method is by soaking in 20 percent glycerol for 15 minutes.

Because the glutaraldehyde present in the sodium bicarbonate serves as a tanning agent (cross-linking agent), the dried film contains an excess of glutaraldehyde. The wet plasticized porous collagen film is dried and is also slightly compressed, i.e. to about onequarter of its original wet thickness (referring to the gel stage), for example, by being force dried on a heated cam under slight pressure. A typical thickness of the dried compressed collagen foam film at this point is about 12.5 mils.

The compressed collagen foam has been fairly well tanned so that it will not have antigenic activity. One method of determining the sufficiency of amount of tanning is by its resistance to collagenase attack. Here resistance to collagenase attack is assayed according to a procedure described by Mandl, I. in the J. Clinical lnvestigation, 32, I323 (1953). We have found that our cross-linked collagen is essentially resistant to hydrolysis by the enzyme collagenase from Cl. histolyticum. We have reduced the ability of the enzyme to attack the collagen by greater than percent.

ADDITION OF SILVER Where the preferred embodiment is desired, i.e. the use of a fine dispersion of silver throughout the collagen film, one way of adding it is by the use of Tollens reagent; e.g. the dried compressed foam collagen film can be soaked in Tollens reagent for 5 minutes. Tollens reagent, which has the formula Ag(NH Ol-l, is a reducing agent for aldehyde groups, and it serves to oxidize the excess glutaraldehyde and also to deposit silver metal on the accessible surfaces of the collagen fibers throughout the film. The specific amount of silver deposited or impregnated is that which is equivalent to the amount of excess aldehyde which has been oxidized to carboxyl. The silver acts as an antibacterial agent and is especially effective in amounts of from 1.5 mg silver per square inch to 0.5 mg silver per square inch when applied and impregnated in the manner herein suggested.

The collagen film, after being soaked in Tollens reagent for 5 minutes, is then rinsed in water for about an hour and finally plasticized, e.g. by being soaked in 20 percent glycerol for minutes, and it is then air dried.

While there can be a fair amount of variation, a typical compressed collagen foam film formed at this point might have a density of 1.8285 grams per cubic centimeter, a porosity of 76.4 percent, and a measured pore volume of 0.608 cubic centimeters per gram (as determined in the well-known manner on a Porosimeter, the particular machine being that manufactured by the American Instrument Company as their Aminco Digital Readout Porosimeter, 15,000 PSI Motor Driven).

LAMINATION TO THIN PLASTIC FILM The plasticized compressed collagen foam film is now ready to be coated with a plasticfilm. While it is physically possible to utilize various adhesives to attach the plastic film to the collagen film, animal tests have shown the resultant dressing to be unsatisfactory since they delaminated in actual use, wherefore the plastic film used in the present invention is laminated to the collagen film without any adhesive. While this can be accomplished various ways, we have found solvent casting to be quite satisfactory, i.e. dissolving the plastic in a solvent and then cast coating the collagen film with the dissolved plastic. The plastic we prefer is polyurethane, although other plastics ought work provided they give the desired moisture vapor transmission rates (slightly higher than that of skin) and do not release toxic or irritant chemiclas to the wound bed. The particular preferred polyurethane is a thermoplastic polyurethane sold by the B. F. Goodrich Chemical Company as Tuftane packaging film and which has high elongation and excellent stretch recovery properties as well as good strength and toughness. We have used their Tuftane No. 1 1O film in 1.0 mil thickness and dissolved it in an organic solvent, such as tetrahydrofuran. A dispersion of percent polyurethane in tetrahydrofuran was found particularly suitable. This was used to coat the compressed collagen foam film using a number 60 Meyer Rod to apply five coatings. The number of coatings could vary since the real control is obtaining the desired moisture vapor transmission rate. This rate will decrease as the plastic film is made thicker.

Naturally the dressing should be sterilized before use. Cobalt irradiation is the method of choice, but other methods could be used also.

Typical examples of dressings of this invention such as illustrated in the drawings and their construction are as follows.

Example 1 Dressing With Silver Starting with the collagen sold as Avitene by FMC Corporation, an equal parts blend of 25, 35, and 50 mesh collagen fibers are made into a 3.5 percent by weight aqueous dispersion containing 15 percent by volume petroleum ether, which immediately forms a gel. The fibers in the gel are subjected to attrition for 30 seconds at high speed in a Waring-blender. The dispersion of fibers still in the gel state is allowed to standfor one hour. The resultant gel is spread into a 50 mil thick wet film. This wet film is soaked in a 5 percent sodium bicarbonate solution containing 400 ppm glutaraldehyde for 1 hour, which makes the wet film porous. The bicarbonate neutralized porous collagen film is' then air dried. The dried film is rinsed with water for 1 hour and is then soaked in 20 percent glycerol for 15 minutes. The film is then force dried on a heated cam under slight pressure using a Bessler photographic dryer which used a coarse mesh nylon belt (in place of the usual cotton belt) to provide faster heat exchange. The dried film is soaked in Tollens reagent, Ag( NH OH, for 5 minutes, rinsed in water for 1 hour, and finally soaked in 20 percent glycerol for 15 minutes. It is then air dried. The resultant dried compressed tanned collagen foam film, which is about 12-15 mils thick, is then coated 5 times (with air drying after each coat) with a dispersion of 20 percent Tuftane l 10 polyurethane in tetrahydrofuran using a No. Meyer rod, which resulted in the addition to the collagen layer of a polyurethane film about 3-5 mils thick. This was then dried. The resultant laminated film of polyurethane on a compressed foam collagen film has a moisture vapor transmission rate of about 3 mg/hr/cm The dressing was sterilized by being subjected to 2.5 megarods of cobalt irradiation and was then suitable for use as a surgical dressing, particularly for burns.

The above dressing was tested on a Aminco Porosimeter and the collagen portion was found to have a porosity of 75.7 percent, of which 51 percent was from pores having pore diameters larger than 95.264 microns, and the other 24.7 percent was fairly well distributed among a very wide range of smaller pores, e.g. 6.3 percent was from pores ranging from 14.71 down to 10.13 microns, and there were 0.2 percent pores as small as 0.0160.013 microns. This indicates a welldistributed porous collagen structure with varying size pores.

Example 2 Dressing Without Silver Example 1 was repeated except that no silver metal was impregnated in the collagen layer, i.e. the step of soaking in Tollens reagent was omitted. The resultant dressing was substantially identical to that of Example 1 except that it does not contain any silver.

The bacteriostatic activity advantage of the silverimpregnated dressing of Example 1 over the non-silver dressing of Example 2 is unexpectedly high and is demonstrated dramatically by a zone of inhibition microbiological test procedure wherein a culture is made from beef serum containing some 6,000 viable cells of Pseudomonas aeruginosa, which has been incubated and placed on an agar plate, and 1 inch discs of the dressing of Example 1 and of the dressing of Example 2 are placed, collagen side down, on the surface of the agar. The zone of inhibition for the Example I silver-- containing dressing disc was 32.3 mm. while that for the Example 2 non-silver impregnated dressing disc was 0.

RELATED UNSUCCESSFUL PRODUCTS Similar materials to those used in the dressing of our invention have been used by us in dressings made by different constructions, for example, through the use of adhesives, and these have failed because of delamination in animal tests. Collagen films have also been made by us as dense continuous sheets which were de-aired in the gel state before they were cast into a film and so lacked the porosity of the present collagen film. These nonporous collagen films failed in critical tests on certain species of experimental animals although they appeared satisfactory on other species of animals.

The dressings of the present invention have been successfully evaluated on a number of different experimental animals. The dressings were evaluated on full thickness skin injuries using rats and rabbits. Dressings were applied and the healing response was observed over a 4-7 day period. The results indicated a wound bed suitable for grafting.

The dressings of the present invention are elastic, pliable, flexible, soft, and have the ability when wet out to conform to the topography of the wound site.

Particular embodiments of the invention have been used to illustrate the same. The invention, however, is not limited to these specific embodiments. In view of the foregoing disclosure, variations or modifications thereof will be apparent, and it is intended to include within the invention all such variations and modifications except as do not come within the scope of the appended claims.

We claim:

. l. A pliable, surgical dressing especially useful in the treatment of burns, comprising a thicker layer of a compressed, tanned collagen foam film and laminated to one surface of said compressed foam, a thinner layer of plastic film having a moisture vapor transmission rate from 2-7 mglhr/cm 2. The dressing of claim 1 wherein the plastic film is polyurethane.

3. The dressing 'of claim 1 wherein the compressed collagen foam layer is 3-30 mils thick.

4. A pliable, surgical dressing especially useful in the treatment of burns, comprising a thicker layer of compressed, tanned collagen foam film having silver metal impregnated therein and laminated to one surface of said compressed foam, an outer thinner layer of plastic film having a moisture vapor transmission rate from 2-7 mg/hr/cm 5. The dressing of claim 4 wherein the plastic film is polyurethane.

6. The dressing of claim 4 wherein the amount of silver metal is from 0.5-1.5 mg silver per square inch of collagen film.

7. The dressing of claim 4 wherein the compressed collagen foam layer is 3-30 mils thick.

Claims (6)

  1. 2. The dressing of claim 1 wherein the plastic film is polyurethane.
  2. 3. The dressing of claim 1 wherein the compressed collagen foam layer is 3-30 mils thick.
  3. 4. A pliable, surgical dressing especially useful in the treatment of burns, comprising a thicker layer of compressed, tanned collagen foam film having silver metal impregnated therein and laminated to one surface of said compressed foam, an outer thinner layer of plastic film having a moisture vapor transmission rate from 2-7 mg/hr/cm2.
  4. 5. The dressing of claim 4 wherein the plastic film is polyurethane.
  5. 6. The dressing of claim 4 wherein the amount of silver metal is from 0.5-1.5 mg silver per square inch of collagen film.
  6. 7. The dressing of claim 4 wherein the compressed collagen foam layer is 3-30 mils thick.
US3800792A 1972-04-17 1972-04-17 Laminated collagen film dressing Expired - Lifetime US3800792A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US24443972 true 1972-04-17 1972-04-17

Publications (1)

Publication Number Publication Date
US3800792A true US3800792A (en) 1974-04-02

Family

ID=22922775

Family Applications (1)

Application Number Title Priority Date Filing Date
US3800792A Expired - Lifetime US3800792A (en) 1972-04-17 1972-04-17 Laminated collagen film dressing

Country Status (1)

Country Link
US (1) US3800792A (en)

Cited By (135)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896802A (en) * 1974-04-19 1975-07-29 American Cyanamid Co Flexible flocked dressing
US3903882A (en) * 1974-04-19 1975-09-09 American Cyanamid Co Composite dressing
US3949742A (en) * 1974-09-20 1976-04-13 Frigitronics, Inc. Medical dressing
FR2332863A1 (en) * 1975-07-15 1977-06-24 Massachusetts Inst Technology Membrane useful as multi-layer synthetic skin
EP0006714A1 (en) * 1978-06-29 1980-01-09 Johnson & Johnson Balanced environment wound dressing
US4233969A (en) * 1976-11-11 1980-11-18 Lock Peter M Wound dressing materials
US4306563A (en) * 1979-11-28 1981-12-22 Firma Pfrimmer & Co. Pharmazeutische Werke Erlangen Gmbh Catheter for introduction into body cavities
FR2503561A1 (en) * 1981-04-13 1982-10-15 Seton Co continuous flexible film cosmetics and pharmaceuticals containing polypeptides
EP0068777A2 (en) * 1981-06-26 1983-01-05 Minnesota Mining And Manufacturing Company Composite wound dressing
FR2524304A1 (en) * 1982-03-31 1983-10-07 Delalande Sa artificial skin
JPS59181158A (en) * 1983-03-30 1984-10-15 Nitto Electric Ind Co Wound cover agent
US4505266A (en) * 1981-10-26 1985-03-19 Massachusetts Institute Of Technology Method of using a fibrous lattice
JPS6072557A (en) * 1983-09-27 1985-04-24 Nitto Electric Ind Co Wound cover agent
US4554317A (en) * 1982-04-06 1985-11-19 David Behar Synthetic wound covering
EP0167828A1 (en) * 1984-06-11 1986-01-15 Koken Co. Ltd. A man-made skin composed of two layers:Collagen and a poly-alpha-amino acid
EP0227955A2 (en) * 1982-07-21 1987-07-08 University of Strathclyde Composite wound dressing
US4703108A (en) * 1984-03-27 1987-10-27 University Of Medicine & Dentistry Of New Jersey Biodegradable matrix and methods for producing same
US4728323A (en) * 1986-07-24 1988-03-01 Minnesota Mining And Manufacturing Company Antimicrobial wound dressings
US4759354A (en) * 1986-11-26 1988-07-26 The Kendall Company Wound dressing
US4837285A (en) * 1984-03-27 1989-06-06 Medimatrix Collagen matrix beads for soft tissue repair
US4847049A (en) * 1985-12-18 1989-07-11 Vitaphore Corporation Method of forming chelated collagen having bactericidal properties
US4846164A (en) * 1987-08-07 1989-07-11 Martz Joel D Vapor permeable dressing
EP0371736A2 (en) * 1988-11-29 1990-06-06 Mitsubishi Kasei Corporation Wound covering
US4991574A (en) * 1987-07-22 1991-02-12 Dow Corning Corporation Surgical dressing
US4997425A (en) * 1986-10-31 1991-03-05 Nippon Zeon Co., Ltd. Wound dressing
EP0422046A1 (en) * 1988-05-16 1991-04-17 Kensey Nash Corp Device for sealing percutaneous puncture in a vessel.
EP0431479A1 (en) * 1989-12-05 1991-06-12 Hoechst Japan Limited Wound surface-covering sheets
US5061258A (en) * 1987-08-07 1991-10-29 Martz Joel D Vapor permeable dressing with releasable medication
US5149469A (en) * 1989-07-11 1992-09-22 Nippon Zeon Co., Ltd. Method of manufacturing a wound dressing
US5196185A (en) * 1989-09-11 1993-03-23 Micro-Collagen Pharmaceutics, Ltd. Collagen-based wound dressing and method for applying same
DE4227681A1 (en) * 1992-08-21 1994-02-24 Becker & Co Naturinwerk Wound covering material based on collagen fibers
EP0653214A1 (en) * 1993-11-11 1995-05-17 YISSUM RESEARCH DEVELOPMENT COMPANY of the Hebrew University of Jerusalem Topical antibacterial preparation
EP0666082A1 (en) * 1994-02-04 1995-08-09 Pharmalett International B.V. Laminate for treating wounds
US5516395A (en) * 1988-09-22 1996-05-14 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Process for the production of collagen foams in the form of continuous tapes and their use in medicine, cosmetics and hygiene
US5554106A (en) * 1994-10-13 1996-09-10 Quinton Instrument Company Hydrocolloid exit site dressing
US5569207A (en) * 1994-10-13 1996-10-29 Quinton Instrument Company Hydrocolloid dressing
US5593395A (en) * 1987-08-07 1997-01-14 Martz; Joel D. Vapor permeable dressing
US5676967A (en) * 1995-04-18 1997-10-14 Brennen Medical, Inc. Mesh matrix wound dressing
US5709934A (en) * 1994-11-22 1998-01-20 Tissue Engineering, Inc. Bipolymer foams having extracellular matrix particulates
US5814328A (en) * 1997-01-13 1998-09-29 Gunasekaran; Subramanian Preparation of collagen using papain and a reducing agent
US5814094A (en) * 1996-03-28 1998-09-29 Becker; Robert O. Iontopheretic system for stimulation of tissue healing and regeneration
US5868778A (en) * 1995-10-27 1999-02-09 Vascular Solutions, Inc. Vascular sealing apparatus and method
US5891558A (en) * 1994-11-22 1999-04-06 Tissue Engineering, Inc. Biopolymer foams for use in tissue repair and reconstruction
US5957952A (en) * 1993-05-25 1999-09-28 Vascular Solutions, Inc. Vascular sealing device
US6007563A (en) * 1991-11-08 1999-12-28 Kensey Nash Corporation Method of deploying percutaneous puncture closure
US6017359A (en) * 1993-05-25 2000-01-25 Vascular Solutions, Inc. Vascular sealing apparatus
US6080490A (en) * 1990-12-24 2000-06-27 Westaim Technologies Inc. Actively sterile surfaces
US6103369A (en) * 1989-12-29 2000-08-15 3M Innovative Properties Company Multi-layered dressing
US20020013300A1 (en) * 2000-03-17 2002-01-31 Avocet Polymer Technologies, Inc. Methods for improving size and appearance of a wound
US20020028243A1 (en) * 1998-09-25 2002-03-07 Masters David B. Protein matrix materials, devices and methods of making and using thereof
US6365220B1 (en) 1997-11-03 2002-04-02 Nucryst Pharmaceuticals Corp. Process for production of actively sterile surfaces
US20020173806A1 (en) * 1996-08-30 2002-11-21 Verigen Transplantation Service International (Vtsi) Ag Method for autologous transplantation
US20030007991A1 (en) * 1998-09-25 2003-01-09 Masters David B. Devices including protein matrix materials and methods of making and using thereof
US20030021854A1 (en) * 2001-04-23 2003-01-30 Burrell Robert Edward Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals
WO2003047643A1 (en) * 2001-12-06 2003-06-12 Johnson & Johnson Medical Limited Controlled release therapeutic wound dressings
US6582713B2 (en) 2000-04-06 2003-06-24 Univ. Of Colorado - Colorado Springs Compositions and methods for promoting wound healing
US20030180378A1 (en) * 2000-07-27 2003-09-25 Gillis Scott H. Dry powders of metal-containing compounds
US20030203046A1 (en) * 2000-07-27 2003-10-30 Burrell Robert E. Solutions and aerosols of metal-containing compounds
US20030206966A1 (en) * 2000-07-27 2003-11-06 Burrell Robert E. Methods of inducing apoptosis and modulating metalloproteinases
US20030211793A1 (en) * 2001-03-05 2003-11-13 Eugene Bell Injectable bio-compatible material and methods of use
WO2003099230A2 (en) * 2002-05-28 2003-12-04 Virginia Commonwealth University Intellectual Property Foundation Electroprocessed collagen and tissue engineering
US6680113B1 (en) 1989-12-29 2004-01-20 3M Innovative Properties Company Multi-layered dressing
US20040030276A1 (en) * 1997-09-22 2004-02-12 Flick Bart A. Conductive wound dressings and methods of use
US6692773B2 (en) 2000-07-27 2004-02-17 Nucryst Pharmaceuticals Corp. Treatment of hyperproliferative skin disorders and diseases
US20040048796A1 (en) * 2002-03-26 2004-03-11 Hariri Robert J. Collagen biofabric and methods of preparation and use therefor
US20040049145A1 (en) * 1997-09-22 2004-03-11 Flick A. Bart Multilayer conductive appliance having wound healing and analgesic properties
US6719987B2 (en) 2000-04-17 2004-04-13 Nucryst Pharmaceuticals Corp. Antimicrobial bioabsorbable materials
US20040131698A1 (en) * 2000-07-27 2004-07-08 Gillis Scott H. Methods of treating conditions using metal-containing materials
US20040129112A1 (en) * 2000-07-27 2004-07-08 Gillis Scott H. Metal-containing materials
US20040136968A1 (en) * 2002-09-27 2004-07-15 Verigen Ag Autologous cells on a support matrix for tissue repair
US20040176312A1 (en) * 2002-04-23 2004-09-09 Gillis Scott H. Treatment of ungual and subungual diseases
US20040180093A1 (en) * 2003-03-12 2004-09-16 3M Innovative Properties Company Polymer compositions with bioactive agent, medical articles, and methods
US20040258738A1 (en) * 2000-12-21 2004-12-23 Kania Bruce G. Treatment devices providing targeted antimicrobial action
US20050123621A1 (en) * 2003-12-05 2005-06-09 3M Innovative Properties Company Silver coatings and methods of manufacture
US20050123590A1 (en) * 2003-12-05 2005-06-09 3M Innovative Properties Company Wound dressings and methods
US20050124724A1 (en) * 2003-12-05 2005-06-09 3M Innovative Properties Company Polymer compositions with bioactive agent, medical articles, and methods
US20050147690A1 (en) * 1998-09-25 2005-07-07 Masters David B. Biocompatible protein particles, particle devices and methods thereof
US20050158364A1 (en) * 2000-11-07 2005-07-21 Cryolife, Inc. Methods of making expandable foam-like biomaterials
US20050163817A1 (en) * 2002-04-29 2005-07-28 Masters David B. Biomatrix structural containment and fixation systems and methods of use thereof
US20050196440A1 (en) * 2003-12-08 2005-09-08 Masters David B. Mucoadhesive drug delivery devices and methods of making and using thereof
US20050244484A1 (en) * 1997-09-22 2005-11-03 Flick A B Multilayer conductive appliance having wound healing and analgesic properties
US20050283256A1 (en) * 2004-02-09 2005-12-22 Codman & Shurtleff, Inc. Collagen device and method of preparing the same
US20060004407A1 (en) * 2004-02-17 2006-01-05 Hiles Michael C Medical devices and methods useful for applying bolster material
US20060004314A1 (en) * 2001-06-14 2006-01-05 Hemcon, Inc. Antimicrobial barriers, systems, and methods formed from hydrophilic polymer structures such as chistosan
US20060025786A1 (en) * 1996-08-30 2006-02-02 Verigen Transplantation Service International (Vtsi) Ag Method for autologous transplantation
US20060034899A1 (en) * 2004-08-12 2006-02-16 Ylitalo Caroline M Biologically-active adhesive articles and methods of manufacture
US20060035039A1 (en) * 2004-08-12 2006-02-16 3M Innovative Properties Company Silver-releasing articles and methods of manufacture
US7001617B2 (en) 2001-04-23 2006-02-21 Nueryst Pharmaceuticals Corp. Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals
US7008647B2 (en) 2001-04-23 2006-03-07 Nucryst Pharmaceuticals Corp. Treatment of acne
US7041868B2 (en) 2000-12-29 2006-05-09 Kimberly-Clark Worldwide, Inc. Bioabsorbable wound dressing
US20060149040A1 (en) * 2002-05-21 2006-07-06 John Snowden Collagen and method for producing same
US20060167540A1 (en) * 2003-06-17 2006-07-27 Masters David B Encapsulated or coated stent systems
US20060173087A1 (en) * 2003-03-12 2006-08-03 Hyde Patrick D Absorbent polymer compositions, medical articles, and methods
US20060210960A1 (en) * 1990-09-12 2006-09-21 Lifecell Corporation, A Texas Corporation Method for processing and preserving collagen-based tissues for transplantation
US20060211973A1 (en) * 2005-03-17 2006-09-21 Gregory Kenton W Systems and methods for hemorrhage control and or tissue repair
US20060233889A1 (en) * 2005-04-14 2006-10-19 3M Innovative Properties Company Silver coatings and methods of manufacture
US7137968B1 (en) 2000-03-13 2006-11-21 Nucryst Pharmaceuticals Corp. Transcutaneous medical device dressings and method of use
US20060264796A1 (en) * 1995-09-05 2006-11-23 Argentum Medical, Llc Medical device
US20070014755A1 (en) * 2005-07-01 2007-01-18 Beckman Eric J Wound healing polymeric networks
US20070038298A1 (en) * 2005-06-30 2007-02-15 Sulner Joseph W Repair of tympanic membrane using placenta derived collagen biofabric
US20070073415A1 (en) * 2005-09-29 2007-03-29 Codman And Shurtleff, Inc. Dural graft and method of preparing the same
US7214847B1 (en) 1997-09-22 2007-05-08 Argentum Medical, L.L.C. Multilayer conductive appliance having wound healing and analgesic properties
US20070166399A1 (en) * 2006-01-13 2007-07-19 3M Innovative Properties Company Silver-containing antimicrobial articles and methods of manufacture
US20080063694A1 (en) * 2006-09-07 2008-03-13 Biolargo Life Technologies, Incorporated Material having antimicrobial activity when wet
US20080069895A1 (en) * 2006-08-15 2008-03-20 Qing Liu Umbilical cord biomaterial for medical use
US7358284B2 (en) 1998-06-19 2008-04-15 Lifecell Corporation Particulate acellular tissue matrix
US20080121592A1 (en) * 2006-09-07 2008-05-29 Biolargo Life Technologies, Incorporated Systems and methods for cleaning liquid carriers related applications data
US20080131522A1 (en) * 2006-10-03 2008-06-05 Qing Liu Use of placental biomaterial for ocular surgery
WO2008065329A2 (en) * 2006-11-30 2008-06-05 Systagenix Wound Management Ip Co. B.V. Protein sheet material
US20080146983A1 (en) * 2006-12-19 2008-06-19 Biopol Co., Ltd. Polyurethane foam dressing with improved moisturization
US20080146984A1 (en) * 2002-06-14 2008-06-19 Hemcon Medical Technologies, Inc. Method for preparing a compressed wound dressing
US20080181935A1 (en) * 2006-10-06 2008-07-31 Mohit Bhatia Human placental collagen compositions, and methods of making and using the same
US20080287907A1 (en) * 2006-05-23 2008-11-20 Providence Health System-Oregan D/B/A Providence St. Vincent Medical Center Systems and methods for introducing and applying a bandage structure within a body lumen or hollow body organ
US7470437B2 (en) 2000-07-27 2008-12-30 Nucryst Pharmaceuticals Corp. Methods of treating conditions with a metal-containing material
US20090018479A1 (en) * 2002-06-14 2009-01-15 Hemcon Medical Technologies, Inc. Absorbable tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chistosan
US20090028915A1 (en) * 2006-09-07 2009-01-29 Biolargo Life Technologies, Incorporated Material having antimicrobial activity when wet
US20090069736A1 (en) * 2002-10-29 2009-03-12 Biopol Co., Ltd. Polyurethane Foam Dressing for Wound Filler and Method for Manufacturing Thereof
US7517536B2 (en) 2005-11-25 2009-04-14 Feng Chia University Antimicrobial compositions and wound dressings
US20090128716A1 (en) * 2007-11-15 2009-05-21 Funai Electric Co., Ltd. Projector and method for projecting image
US20090211693A1 (en) * 2005-12-16 2009-08-27 Molynlycke Health Care Ab Method for perforating heat meltable material
US20090269413A1 (en) * 2008-04-23 2009-10-29 Codman & Shurtleff, Inc. Flowable collagen material for dural closure
US20100098949A1 (en) * 2006-10-18 2010-04-22 Burton Scott A Antimicrobial articles and method of manufacture
US20100143487A1 (en) * 2007-12-26 2010-06-10 Gel-Del Technologies, Inc. Biocompatible protein-based particles and methods thereof
US20100172958A1 (en) * 2008-05-02 2010-07-08 Hemcon Medical Technologies, Inc. Wound dressing devices and methods
US20110034410A1 (en) * 2002-06-14 2011-02-10 Mccarthy Simon J Wound dressing and method for controlling severe, life-threatening bleeding
US20110104303A1 (en) * 2006-09-07 2011-05-05 Biolargo Life Technologies, Inc. Material having antimicrobial activity when wet
DE202011100392U1 (en) 2011-05-07 2011-06-09 Neubauer, Norbert, 38820 Burns Edition
US20110143312A1 (en) * 2001-06-14 2011-06-16 Hemcon Medical Technologies, Inc. Compositions, assemblies, and methods applied during or after a dental procedure to ameliorate fluid loss and/or promote healing, using a hydrophilic polymer sponge structure such as chitosan
US8071135B2 (en) 2006-10-04 2011-12-06 Anthrogenesis Corporation Placental tissue compositions
WO2013135478A1 (en) * 2012-03-13 2013-09-19 Aap Biomaterials Gmbh Antibacterial sheet material that can be used as a wound dressing and method for producing same
US8741335B2 (en) 2002-06-14 2014-06-03 Hemcon Medical Technologies, Inc. Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as Chitosan
US9089366B2 (en) 2013-04-04 2015-07-28 Steven Garner-Richards System for tracking surgical objects
US20160129151A1 (en) * 2014-11-06 2016-05-12 Case Western Reserve University Protein based materials
US9403953B2 (en) 2011-07-06 2016-08-02 Diversified Global Technologies, Llc Cosmetic sponge and method for providing a cosmetic sponge
US9849611B2 (en) 2012-03-13 2017-12-26 Aap Biomaterials Gmbh Method for producing collagen-containing sheet material

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2194677A (en) * 1938-12-19 1940-03-26 Herman J Schneiderwirth Silver animal mucin and process for producing same
US2272728A (en) * 1941-01-13 1942-02-10 Rosenzweig Sam Process for imparting bactericidal and sterilizing properties to natural sponges
US2785153A (en) * 1954-09-13 1957-03-12 Crookes Barnes Lab Inc Silver protein
US2785154A (en) * 1954-09-13 1957-03-12 Crookes Barnes Lab Inc Process of producing a stable silver protein composition
US2858830A (en) * 1956-10-01 1958-11-04 Frank C Lowe Surgical dressing
US3113568A (en) * 1961-12-26 1963-12-10 Eric K Erskine Styptic bandage
US3471598A (en) * 1966-02-14 1969-10-07 Fmc Corp Method of producing absorbent mats
US3491760A (en) * 1965-07-09 1970-01-27 Braun Intern Gmbh B Wound coverings
GB1195062A (en) * 1966-05-27 1970-06-17 Fmc Corp Structures comprising Microcrystalline Collagen and Methods of Forming them.
US3628974A (en) * 1966-05-27 1971-12-21 Fmc Corp Microcrystalline collagen, an ionizable partial salt of collagen and foods, pharmaceuticals and cosmetics containing same

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2194677A (en) * 1938-12-19 1940-03-26 Herman J Schneiderwirth Silver animal mucin and process for producing same
US2272728A (en) * 1941-01-13 1942-02-10 Rosenzweig Sam Process for imparting bactericidal and sterilizing properties to natural sponges
US2785153A (en) * 1954-09-13 1957-03-12 Crookes Barnes Lab Inc Silver protein
US2785154A (en) * 1954-09-13 1957-03-12 Crookes Barnes Lab Inc Process of producing a stable silver protein composition
US2858830A (en) * 1956-10-01 1958-11-04 Frank C Lowe Surgical dressing
US3113568A (en) * 1961-12-26 1963-12-10 Eric K Erskine Styptic bandage
US3491760A (en) * 1965-07-09 1970-01-27 Braun Intern Gmbh B Wound coverings
US3471598A (en) * 1966-02-14 1969-10-07 Fmc Corp Method of producing absorbent mats
GB1195062A (en) * 1966-05-27 1970-06-17 Fmc Corp Structures comprising Microcrystalline Collagen and Methods of Forming them.
US3628974A (en) * 1966-05-27 1971-12-21 Fmc Corp Microcrystalline collagen, an ionizable partial salt of collagen and foods, pharmaceuticals and cosmetics containing same

Cited By (244)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896802A (en) * 1974-04-19 1975-07-29 American Cyanamid Co Flexible flocked dressing
US3903882A (en) * 1974-04-19 1975-09-09 American Cyanamid Co Composite dressing
US3949742A (en) * 1974-09-20 1976-04-13 Frigitronics, Inc. Medical dressing
FR2332863A1 (en) * 1975-07-15 1977-06-24 Massachusetts Inst Technology Membrane useful as multi-layer synthetic skin
US4060081A (en) * 1975-07-15 1977-11-29 Massachusetts Institute Of Technology Multilayer membrane useful as synthetic skin
US4233969A (en) * 1976-11-11 1980-11-18 Lock Peter M Wound dressing materials
EP0006714A1 (en) * 1978-06-29 1980-01-09 Johnson & Johnson Balanced environment wound dressing
US4306563A (en) * 1979-11-28 1981-12-22 Firma Pfrimmer & Co. Pharmazeutische Werke Erlangen Gmbh Catheter for introduction into body cavities
FR2503561A1 (en) * 1981-04-13 1982-10-15 Seton Co continuous flexible film cosmetics and pharmaceuticals containing polypeptides
EP0068777A2 (en) * 1981-06-26 1983-01-05 Minnesota Mining And Manufacturing Company Composite wound dressing
EP0068777A3 (en) * 1981-06-26 1983-06-29 Minnesota Mining And Manufacturing Company Composite wound dressing
US4505266A (en) * 1981-10-26 1985-03-19 Massachusetts Institute Of Technology Method of using a fibrous lattice
FR2524304A1 (en) * 1982-03-31 1983-10-07 Delalande Sa artificial skin
US4554317A (en) * 1982-04-06 1985-11-19 David Behar Synthetic wound covering
EP0227955A3 (en) * 1982-07-21 1987-11-25 University of Strathclyde Composite wound dressing
EP0227955A2 (en) * 1982-07-21 1987-07-08 University of Strathclyde Composite wound dressing
JPS6346702B2 (en) * 1983-03-30 1988-09-16 Nitto Electric Ind Co
JPS59181158A (en) * 1983-03-30 1984-10-15 Nitto Electric Ind Co Wound cover agent
JPS6072557A (en) * 1983-09-27 1985-04-24 Nitto Electric Ind Co Wound cover agent
JPS6340543B2 (en) * 1983-09-27 1988-08-11 Nitto Electric Ind Co
US4703108A (en) * 1984-03-27 1987-10-27 University Of Medicine & Dentistry Of New Jersey Biodegradable matrix and methods for producing same
US4837285A (en) * 1984-03-27 1989-06-06 Medimatrix Collagen matrix beads for soft tissue repair
EP0167828A1 (en) * 1984-06-11 1986-01-15 Koken Co. Ltd. A man-made skin composed of two layers:Collagen and a poly-alpha-amino acid
US4847049A (en) * 1985-12-18 1989-07-11 Vitaphore Corporation Method of forming chelated collagen having bactericidal properties
US4728323A (en) * 1986-07-24 1988-03-01 Minnesota Mining And Manufacturing Company Antimicrobial wound dressings
US4997425A (en) * 1986-10-31 1991-03-05 Nippon Zeon Co., Ltd. Wound dressing
US4759354A (en) * 1986-11-26 1988-07-26 The Kendall Company Wound dressing
US4991574A (en) * 1987-07-22 1991-02-12 Dow Corning Corporation Surgical dressing
US5061258A (en) * 1987-08-07 1991-10-29 Martz Joel D Vapor permeable dressing with releasable medication
US4846164A (en) * 1987-08-07 1989-07-11 Martz Joel D Vapor permeable dressing
US5593395A (en) * 1987-08-07 1997-01-14 Martz; Joel D. Vapor permeable dressing
EP0422046A4 (en) * 1988-05-16 1991-06-19 Kensey Nash Corporation Device for sealing percutaneous puncture in a vessel
EP0422046A1 (en) * 1988-05-16 1991-04-17 Kensey Nash Corp Device for sealing percutaneous puncture in a vessel.
US5516395A (en) * 1988-09-22 1996-05-14 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Process for the production of collagen foams in the form of continuous tapes and their use in medicine, cosmetics and hygiene
EP0371736A2 (en) * 1988-11-29 1990-06-06 Mitsubishi Kasei Corporation Wound covering
EP0371736A3 (en) * 1988-11-29 1990-12-27 Mitsubishi Kasei Corporation Wound covering
US5149469A (en) * 1989-07-11 1992-09-22 Nippon Zeon Co., Ltd. Method of manufacturing a wound dressing
US5298015A (en) * 1989-07-11 1994-03-29 Nippon Zeon Co., Ltd. Wound dressing having a porous structure
US5196185A (en) * 1989-09-11 1993-03-23 Micro-Collagen Pharmaceutics, Ltd. Collagen-based wound dressing and method for applying same
EP0431479A1 (en) * 1989-12-05 1991-06-12 Hoechst Japan Limited Wound surface-covering sheets
US6680113B1 (en) 1989-12-29 2004-01-20 3M Innovative Properties Company Multi-layered dressing
US6103369A (en) * 1989-12-29 2000-08-15 3M Innovative Properties Company Multi-layered dressing
US20060210960A1 (en) * 1990-09-12 2006-09-21 Lifecell Corporation, A Texas Corporation Method for processing and preserving collagen-based tissues for transplantation
US6080490A (en) * 1990-12-24 2000-06-27 Westaim Technologies Inc. Actively sterile surfaces
US6007563A (en) * 1991-11-08 1999-12-28 Kensey Nash Corporation Method of deploying percutaneous puncture closure
US6022557A (en) * 1992-08-21 2000-02-08 Naturin Gmbh & Co. Material on the basis of collagen fibers for covering wounds
DE4227681A1 (en) * 1992-08-21 1994-02-24 Becker & Co Naturinwerk Wound covering material based on collagen fibers
US6296658B1 (en) 1993-05-25 2001-10-02 Vascular Solutions, Inc. Vascular sealing apparatus
US6017359A (en) * 1993-05-25 2000-01-25 Vascular Solutions, Inc. Vascular sealing apparatus
US5957952A (en) * 1993-05-25 1999-09-28 Vascular Solutions, Inc. Vascular sealing device
EP0653214A1 (en) * 1993-11-11 1995-05-17 YISSUM RESEARCH DEVELOPMENT COMPANY of the Hebrew University of Jerusalem Topical antibacterial preparation
US5514657A (en) * 1993-11-11 1996-05-07 Yissum Research Development Company Of The Hebrew University Topical antibacterial preparation
EP0666082A1 (en) * 1994-02-04 1995-08-09 Pharmalett International B.V. Laminate for treating wounds
US5569207A (en) * 1994-10-13 1996-10-29 Quinton Instrument Company Hydrocolloid dressing
US5554106A (en) * 1994-10-13 1996-09-10 Quinton Instrument Company Hydrocolloid exit site dressing
US5891558A (en) * 1994-11-22 1999-04-06 Tissue Engineering, Inc. Biopolymer foams for use in tissue repair and reconstruction
US5948429A (en) * 1994-11-22 1999-09-07 Tissue Engineering, Inc. Methods for preparing biopolymer foams
US5709934A (en) * 1994-11-22 1998-01-20 Tissue Engineering, Inc. Bipolymer foams having extracellular matrix particulates
US6153292A (en) * 1994-11-22 2000-11-28 Tissue Engineering, Inc. Biopolymer foams for use in tissue repair and reconstruction
US5676967A (en) * 1995-04-18 1997-10-14 Brennen Medical, Inc. Mesh matrix wound dressing
US8283513B2 (en) 1995-09-05 2012-10-09 Argentum Medical, Llc Multilayer wound dressing
US20070179522A1 (en) * 1995-09-05 2007-08-02 Argentum Medical, Llc Multilayer wound dressing
US7005556B1 (en) 1995-09-05 2006-02-28 Argentum Medical Multilayer wound dressing
US8801681B2 (en) 1995-09-05 2014-08-12 Argentum Medical, Llc Medical device
US8293964B2 (en) 1995-09-05 2012-10-23 Argentum Medical, Llc Multilayer laminate wound dressing
US20080114279A1 (en) * 1995-09-05 2008-05-15 Argentum Medical, Llc Multilayer laminate wound dressing
US8118791B2 (en) 1995-09-05 2012-02-21 Argentum Medical, Llc Medical device
US20060264796A1 (en) * 1995-09-05 2006-11-23 Argentum Medical, Llc Medical device
US5868778A (en) * 1995-10-27 1999-02-09 Vascular Solutions, Inc. Vascular sealing apparatus and method
US5814094A (en) * 1996-03-28 1998-09-29 Becker; Robert O. Iontopheretic system for stimulation of tissue healing and regeneration
US20020173806A1 (en) * 1996-08-30 2002-11-21 Verigen Transplantation Service International (Vtsi) Ag Method for autologous transplantation
US20060025786A1 (en) * 1996-08-30 2006-02-02 Verigen Transplantation Service International (Vtsi) Ag Method for autologous transplantation
US5814328A (en) * 1997-01-13 1998-09-29 Gunasekaran; Subramanian Preparation of collagen using papain and a reducing agent
US6548077B1 (en) 1997-01-13 2003-04-15 Subramanian Gunasekaran Purifying type I collagen using two papain treatments and reducing and delipidation agents
US8093444B2 (en) 1997-09-22 2012-01-10 Argentum Medical, Llc Multilayer conductive appliance having wound healing and analgesic properties
US7291762B2 (en) 1997-09-22 2007-11-06 Argentum International, Llc Multilayer conductive appliance having wound healing and analgesic properties
US6861570B1 (en) 1997-09-22 2005-03-01 A. Bart Flick Multilayer conductive appliance having wound healing and analgesic properties
US20080033506A1 (en) * 1997-09-22 2008-02-07 Argentum International, Llc Multilayer Conductive Appliance Having Wound Healing and Analgesic Properties
EP1864634A2 (en) 1997-09-22 2007-12-12 Argentum International, LLC Multilayer conductive appliance having wound healing and analgesic properties
US20040049145A1 (en) * 1997-09-22 2004-03-11 Flick A. Bart Multilayer conductive appliance having wound healing and analgesic properties
EP2316524A1 (en) 1997-09-22 2011-05-04 Argentum International, LLC Multilayer conductive appliance having wound healing and analgesic properties
US20050244484A1 (en) * 1997-09-22 2005-11-03 Flick A B Multilayer conductive appliance having wound healing and analgesic properties
US7989674B2 (en) 1997-09-22 2011-08-02 Argentum Medical, Llc Multilayer conductive appliance having wound healing and analgesic properties
US7230153B2 (en) 1997-09-22 2007-06-12 Argentum International, Llc Multilayer conductive appliance having wound healing and analgesic properties
US7214847B1 (en) 1997-09-22 2007-05-08 Argentum Medical, L.L.C. Multilayer conductive appliance having wound healing and analgesic properties
US20040030276A1 (en) * 1997-09-22 2004-02-12 Flick Bart A. Conductive wound dressings and methods of use
US8449514B2 (en) 1997-09-22 2013-05-28 Argentum Medical, Llc Conductive wound dressings and methods of use
US8455710B2 (en) * 1997-09-22 2013-06-04 Argentum Medical, Llc Conductive wound dressings and methods of use
US6365220B1 (en) 1997-11-03 2002-04-02 Nucryst Pharmaceuticals Corp. Process for production of actively sterile surfaces
US7358284B2 (en) 1998-06-19 2008-04-15 Lifecell Corporation Particulate acellular tissue matrix
US20020028243A1 (en) * 1998-09-25 2002-03-07 Masters David B. Protein matrix materials, devices and methods of making and using thereof
US8871267B2 (en) 1998-09-25 2014-10-28 Gel-Del Technologies, Inc. Protein matrix materials, devices and methods of making and using thereof
US20100196478A1 (en) * 1998-09-25 2010-08-05 Gel-Del Technologies, Inc. Protein matrix materials, devices and methods of making and using thereof
US20050147690A1 (en) * 1998-09-25 2005-07-07 Masters David B. Biocompatible protein particles, particle devices and methods thereof
US20030007991A1 (en) * 1998-09-25 2003-01-09 Masters David B. Devices including protein matrix materials and methods of making and using thereof
US7662409B2 (en) 1998-09-25 2010-02-16 Gel-Del Technologies, Inc. Protein matrix materials, devices and methods of making and using thereof
US7137968B1 (en) 2000-03-13 2006-11-21 Nucryst Pharmaceuticals Corp. Transcutaneous medical device dressings and method of use
US20070010778A1 (en) * 2000-03-13 2007-01-11 Nucryst Pharmaceuticals Corp., A Canadian Corporation Transcutaneous medical device dressings and method of use
US20020013300A1 (en) * 2000-03-17 2002-01-31 Avocet Polymer Technologies, Inc. Methods for improving size and appearance of a wound
US6582713B2 (en) 2000-04-06 2003-06-24 Univ. Of Colorado - Colorado Springs Compositions and methods for promoting wound healing
US6719987B2 (en) 2000-04-17 2004-04-13 Nucryst Pharmaceuticals Corp. Antimicrobial bioabsorbable materials
US7078060B2 (en) 2000-07-27 2006-07-18 Nucryst Pharmaceuticals Corp. Solutions and aerosols of metal-containing compounds
US20030203046A1 (en) * 2000-07-27 2003-10-30 Burrell Robert E. Solutions and aerosols of metal-containing compounds
US20040129112A1 (en) * 2000-07-27 2004-07-08 Gillis Scott H. Metal-containing materials
US20030180378A1 (en) * 2000-07-27 2003-09-25 Gillis Scott H. Dry powders of metal-containing compounds
US20080014286A1 (en) * 2000-07-27 2008-01-17 Nucryst Pharmaceuticals Corp., A Canada Corporation Metal-containing materials
US20040131698A1 (en) * 2000-07-27 2004-07-08 Gillis Scott H. Methods of treating conditions using metal-containing materials
US7255881B2 (en) 2000-07-27 2007-08-14 Nucryst Pharmaceuticals Corp. Metal-containing materials
US6692773B2 (en) 2000-07-27 2004-02-17 Nucryst Pharmaceuticals Corp. Treatment of hyperproliferative skin disorders and diseases
US7470437B2 (en) 2000-07-27 2008-12-30 Nucryst Pharmaceuticals Corp. Methods of treating conditions with a metal-containing material
US7427416B2 (en) 2000-07-27 2008-09-23 Nucryst Pharmaceuticals Corp. Methods of treating conditions using metal-containing materials
US6989157B2 (en) 2000-07-27 2006-01-24 Nucryst Pharmaceuticals Corp. Dry powders of metal-containing compounds
US20030206966A1 (en) * 2000-07-27 2003-11-06 Burrell Robert E. Methods of inducing apoptosis and modulating metalloproteinases
US8071124B2 (en) * 2000-11-07 2011-12-06 Cryolife, Inc. Methods of using expandable foam-like biomaterials
US20050158364A1 (en) * 2000-11-07 2005-07-21 Cryolife, Inc. Methods of making expandable foam-like biomaterials
US20050163819A1 (en) * 2000-11-07 2005-07-28 Cryolife, Inc Methods of using expandable foam-like biomaterials
US8057818B2 (en) * 2000-11-07 2011-11-15 Cryolife, Inc. Methods of making expandable foam-like biomaterials
US20040258738A1 (en) * 2000-12-21 2004-12-23 Kania Bruce G. Treatment devices providing targeted antimicrobial action
US7157614B1 (en) 2000-12-21 2007-01-02 Fountainhead, Llc Treatment devices providing targeted antimicrobial action
US7041868B2 (en) 2000-12-29 2006-05-09 Kimberly-Clark Worldwide, Inc. Bioabsorbable wound dressing
US20030211793A1 (en) * 2001-03-05 2003-11-13 Eugene Bell Injectable bio-compatible material and methods of use
US6939568B2 (en) 2001-04-23 2005-09-06 Nucryst Pharmaceuticals Corp. Treatment of inflammatory skin conditions
US20060083792A1 (en) * 2001-04-23 2006-04-20 Nucryst Pharmaceuticals Corp. Therapeutic treatments using the direct application of antimicrobial metal compositions
US20060083777A1 (en) * 2001-04-23 2006-04-20 Nucryst Pharmaceuticals Corp. Treatment of acne
US20060204591A1 (en) * 2001-04-23 2006-09-14 Nucryst Pharamaceuticals Corp., A Canadian Corporation Treatment of mucosal membranes
US7008647B2 (en) 2001-04-23 2006-03-07 Nucryst Pharmaceuticals Corp. Treatment of acne
US7087249B2 (en) 2001-04-23 2006-08-08 Nucryst Pharmaceuticals Corp. Treatment of mucosal membranes
US20030021854A1 (en) * 2001-04-23 2003-01-30 Burrell Robert Edward Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals
US6989156B2 (en) 2001-04-23 2006-01-24 Nucryst Pharmaceuticals Corp. Therapeutic treatments using the direct application of antimicrobial metal compositions
US6723350B2 (en) 2001-04-23 2004-04-20 Nucryst Pharmaceuticals Corp. Lubricious coatings for substrates
US7001617B2 (en) 2001-04-23 2006-02-21 Nueryst Pharmaceuticals Corp. Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals
US20110143312A1 (en) * 2001-06-14 2011-06-16 Hemcon Medical Technologies, Inc. Compositions, assemblies, and methods applied during or after a dental procedure to ameliorate fluid loss and/or promote healing, using a hydrophilic polymer sponge structure such as chitosan
US9004918B2 (en) 2001-06-14 2015-04-14 Hemcon Medical Technologies, Inc. Compositions, assemblies, and methods applied during or after a dental procedure to ameliorate fluid loss and/or promote healing, using a hydrophilic polymer sponge structure such as chitosan
US20060004314A1 (en) * 2001-06-14 2006-01-05 Hemcon, Inc. Antimicrobial barriers, systems, and methods formed from hydrophilic polymer structures such as chistosan
US9132206B2 (en) 2001-06-14 2015-09-15 Hemcon Medical Technologies, Inc. Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as chitosan
EP1435911A4 (en) * 2001-08-03 2010-03-24 Gel Del Technologies Inc Devices including protein matrix materials and methods of making and using same
EP1435911A1 (en) * 2001-08-03 2004-07-14 Gel-Del Technologies, Inc. Devices including protein matrix materials and methods of making and using same
US7732655B2 (en) 2001-12-06 2010-06-08 Systagenix Wound Management (Us), Inc. Controlled release therapeutic wound dressings
WO2003047643A1 (en) * 2001-12-06 2003-06-12 Johnson & Johnson Medical Limited Controlled release therapeutic wound dressings
US20050159695A1 (en) * 2001-12-06 2005-07-21 Cullen Breda M. Controlled release therapeutic wound dressings
EP2700309A1 (en) 2002-03-26 2014-02-26 Anthrogenesis Corporation Collagen biofabric and methods of preparation and use therefor
EP2702871A1 (en) 2002-03-26 2014-03-05 Anthrogenesis Corporation Collagen biofabric and methods of preparation and use therefor
US20040048796A1 (en) * 2002-03-26 2004-03-11 Hariri Robert J. Collagen biofabric and methods of preparation and use therefor
US20040176312A1 (en) * 2002-04-23 2004-09-09 Gillis Scott H. Treatment of ungual and subungual diseases
US7201925B2 (en) 2002-04-23 2007-04-10 Nueryst Pharmaceuticals Corp. Treatment of ungual and subungual diseases
US20050163817A1 (en) * 2002-04-29 2005-07-28 Masters David B. Biomatrix structural containment and fixation systems and methods of use thereof
US8623393B2 (en) 2002-04-29 2014-01-07 Gel-Del Technologies, Inc. Biomatrix structural containment and fixation systems and methods of use thereof
US20060149040A1 (en) * 2002-05-21 2006-07-06 John Snowden Collagen and method for producing same
WO2003099230A2 (en) * 2002-05-28 2003-12-04 Virginia Commonwealth University Intellectual Property Foundation Electroprocessed collagen and tissue engineering
WO2003099230A3 (en) * 2002-05-28 2004-06-10 Gary L Bowlin Electroprocessed collagen and tissue engineering
US8741335B2 (en) 2002-06-14 2014-06-03 Hemcon Medical Technologies, Inc. Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as Chitosan
US8269058B2 (en) 2002-06-14 2012-09-18 Hemcon Medical Technologies, Inc. Absorbable tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chitosan
US20110034410A1 (en) * 2002-06-14 2011-02-10 Mccarthy Simon J Wound dressing and method for controlling severe, life-threatening bleeding
US20090018479A1 (en) * 2002-06-14 2009-01-15 Hemcon Medical Technologies, Inc. Absorbable tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chistosan
US8313474B2 (en) 2002-06-14 2012-11-20 Hemcon Medical Technologies, Inc. Method for preparing a compressed wound dressing
US8668924B2 (en) 2002-06-14 2014-03-11 Providence Health System—Oregon Wound dressing and method for controlling severe, life-threatening bleeding
US20080146984A1 (en) * 2002-06-14 2008-06-19 Hemcon Medical Technologies, Inc. Method for preparing a compressed wound dressing
US20070212396A1 (en) * 2002-09-27 2007-09-13 Verigen Ag Autologous cells on a support matrix for tissue repair
US20040136968A1 (en) * 2002-09-27 2004-07-15 Verigen Ag Autologous cells on a support matrix for tissue repair
US7777090B2 (en) 2002-10-29 2010-08-17 Biopol Co., Ltd. Polyurethane foam dressing for wound filler and method for manufacturing thereof
US20090069736A1 (en) * 2002-10-29 2009-03-12 Biopol Co., Ltd. Polyurethane Foam Dressing for Wound Filler and Method for Manufacturing Thereof
US20060173087A1 (en) * 2003-03-12 2006-08-03 Hyde Patrick D Absorbent polymer compositions, medical articles, and methods
US20040180093A1 (en) * 2003-03-12 2004-09-16 3M Innovative Properties Company Polymer compositions with bioactive agent, medical articles, and methods
US7285576B2 (en) 2003-03-12 2007-10-23 3M Innovative Properties Co. Absorbent polymer compositions, medical articles, and methods
US8465537B2 (en) 2003-06-17 2013-06-18 Gel-Del Technologies, Inc. Encapsulated or coated stent systems
US20060167540A1 (en) * 2003-06-17 2006-07-27 Masters David B Encapsulated or coated stent systems
US20110118818A1 (en) * 2003-06-17 2011-05-19 Gel-Del Technologies ,Inc. a corporation Encapsulated or coated stent systems
US20100233273A1 (en) * 2003-12-05 2010-09-16 3M Innovative Properties Company Polymer compositions with bioactive agent, medical articles, and methods
US20050124724A1 (en) * 2003-12-05 2005-06-09 3M Innovative Properties Company Polymer compositions with bioactive agent, medical articles, and methods
US7745509B2 (en) 2003-12-05 2010-06-29 3M Innovative Properties Company Polymer compositions with bioactive agent, medical articles, and methods
US8193267B2 (en) 2003-12-05 2012-06-05 3M Innovative Properties Company Polymer compositions with bioactive agent, medical articles, and methods
US20050123621A1 (en) * 2003-12-05 2005-06-09 3M Innovative Properties Company Silver coatings and methods of manufacture
US20050123590A1 (en) * 2003-12-05 2005-06-09 3M Innovative Properties Company Wound dressings and methods
US8529939B2 (en) 2003-12-08 2013-09-10 Gel-Del Technologies, Inc. Mucoadhesive drug delivery devices and methods of making and using thereof
US20050196440A1 (en) * 2003-12-08 2005-09-08 Masters David B. Mucoadhesive drug delivery devices and methods of making and using thereof
US8951565B2 (en) 2003-12-23 2015-02-10 Hemcon Medical Technologies, Inc. Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as chitosan
US20090030526A1 (en) * 2004-02-09 2009-01-29 Codman & Shurtleff, Inc. Collagen device and method of preparing the same
US8795710B2 (en) 2004-02-09 2014-08-05 Codman & Shurtleff, Inc. Collagen device and method of preparing the same
US20050283256A1 (en) * 2004-02-09 2005-12-22 Codman & Shurtleff, Inc. Collagen device and method of preparing the same
US8920444B2 (en) 2004-02-17 2014-12-30 Cook Biotech Incorporated Medical devices and methods useful for applying bolster material
US9186140B2 (en) 2004-02-17 2015-11-17 Cook Biotech Incorporated Medical devices and methods useful for applying bolster material
US20060004407A1 (en) * 2004-02-17 2006-01-05 Hiles Michael C Medical devices and methods useful for applying bolster material
US20080200949A1 (en) * 2004-02-17 2008-08-21 Hiles Michael C Medical devices and methods useful for applying bolster material
US8920443B2 (en) 2004-02-17 2014-12-30 Cook Biotech Incorporated Medical devices and methods useful for applying bolster material
US20070027472A1 (en) * 2004-02-17 2007-02-01 Hiles Michael C Medical devices and methods useful for applying bolster material
US20060035039A1 (en) * 2004-08-12 2006-02-16 3M Innovative Properties Company Silver-releasing articles and methods of manufacture
US20060034899A1 (en) * 2004-08-12 2006-02-16 Ylitalo Caroline M Biologically-active adhesive articles and methods of manufacture
US9204957B2 (en) 2005-03-17 2015-12-08 Hemcon Medical Technologies, Inc. Systems and methods for hemorrhage control and or tissue repair
US20060211973A1 (en) * 2005-03-17 2006-09-21 Gregory Kenton W Systems and methods for hemorrhage control and or tissue repair
US8399027B2 (en) 2005-04-14 2013-03-19 3M Innovative Properties Company Silver coatings and methods of manufacture
US20060233889A1 (en) * 2005-04-14 2006-10-19 3M Innovative Properties Company Silver coatings and methods of manufacture
US20070038298A1 (en) * 2005-06-30 2007-02-15 Sulner Joseph W Repair of tympanic membrane using placenta derived collagen biofabric
US20070014755A1 (en) * 2005-07-01 2007-01-18 Beckman Eric J Wound healing polymeric networks
US8029774B2 (en) * 2005-07-01 2011-10-04 University Of Pittsburgh Wound healing polymeric networks
US7429241B2 (en) 2005-09-29 2008-09-30 Codman & Shurtleff, Inc. Dural graft and method of preparing the same
US20070073415A1 (en) * 2005-09-29 2007-03-29 Codman And Shurtleff, Inc. Dural graft and method of preparing the same
US20080208359A1 (en) * 2005-09-29 2008-08-28 Codman & Shurtleff, Inc. Dural graft and method of preparing the same
US7517536B2 (en) 2005-11-25 2009-04-14 Feng Chia University Antimicrobial compositions and wound dressings
US20090211693A1 (en) * 2005-12-16 2009-08-27 Molynlycke Health Care Ab Method for perforating heat meltable material
US8177931B2 (en) 2005-12-16 2012-05-15 Molnlycke Health Care Ab Method for perforating heat meltable material
US8192764B2 (en) 2006-01-13 2012-06-05 3M Innovative Properties Company Silver-containing antimicrobial articles and methods of manufacture
US9289450B2 (en) 2006-01-13 2016-03-22 3M Innovative Properties Company Silver-containing antimicrobial articles and methods of manufacture
US20080279960A1 (en) * 2006-01-13 2008-11-13 Burton Scott A Silver-Containing Antimicrobial Articles and Methods of Manufacture
US20070166399A1 (en) * 2006-01-13 2007-07-19 3M Innovative Properties Company Silver-containing antimicrobial articles and methods of manufacture
US20080287907A1 (en) * 2006-05-23 2008-11-20 Providence Health System-Oregan D/B/A Providence St. Vincent Medical Center Systems and methods for introducing and applying a bandage structure within a body lumen or hollow body organ
US8920514B2 (en) 2006-05-23 2014-12-30 Providence Health System—Oregon Systems and methods for introducing and applying a bandage structure within a body lumen or hollow body organ
US8105634B2 (en) 2006-08-15 2012-01-31 Anthrogenesis Corporation Umbilical cord biomaterial for medical use
US20080069895A1 (en) * 2006-08-15 2008-03-20 Qing Liu Umbilical cord biomaterial for medical use
US20080121592A1 (en) * 2006-09-07 2008-05-29 Biolargo Life Technologies, Incorporated Systems and methods for cleaning liquid carriers related applications data
US8226964B2 (en) 2006-09-07 2012-07-24 Biolargo Life Technologies, Inc. Systems and methods for cleaning liquid carriers related applications data
US20080063694A1 (en) * 2006-09-07 2008-03-13 Biolargo Life Technologies, Incorporated Material having antimicrobial activity when wet
US9414601B2 (en) 2006-09-07 2016-08-16 Biolargo Life Technologies, Incorporated Material having antimicrobial activity when wet
US8574610B2 (en) 2006-09-07 2013-11-05 Biolargo Life Technologies, Inc. Material having antimicrobial activity when wet
US7867510B2 (en) 2006-09-07 2011-01-11 BioLargo Life Technologies, Inc Material having antimicrobial activity when wet
US20110104303A1 (en) * 2006-09-07 2011-05-05 Biolargo Life Technologies, Inc. Material having antimicrobial activity when wet
US20090028915A1 (en) * 2006-09-07 2009-01-29 Biolargo Life Technologies, Incorporated Material having antimicrobial activity when wet
US20080131522A1 (en) * 2006-10-03 2008-06-05 Qing Liu Use of placental biomaterial for ocular surgery
US8071135B2 (en) 2006-10-04 2011-12-06 Anthrogenesis Corporation Placental tissue compositions
EP2664341A2 (en) 2006-10-06 2013-11-20 Anthrogenesis Corporation Native (telopeptide) placental collagen compositions
US9770488B2 (en) 2006-10-06 2017-09-26 Anthrogenesis Corporation Human placental collagen compositions, and methods of making and using the same
US9974840B2 (en) 2006-10-06 2018-05-22 Celularity, Inc. Human placental collagen compositions, and methods of making and using the same
US20080181935A1 (en) * 2006-10-06 2008-07-31 Mohit Bhatia Human placental collagen compositions, and methods of making and using the same
US8821857B2 (en) 2006-10-06 2014-09-02 Anthrogenesis Corporation Human placental collagen compositions and methods of making and using the same
US9775886B2 (en) 2006-10-06 2017-10-03 Celularity, Inc. Human placental collagen compositions, and methods of making and using the same
US8877180B2 (en) 2006-10-06 2014-11-04 Anthrogenesis Corporation Human placental collagen compositions, and methods of making and using the same
EP2664342A2 (en) 2006-10-06 2013-11-20 Anthrogenesis Corporation Native (telopeptide) placental collagen compositions
US20100098949A1 (en) * 2006-10-18 2010-04-22 Burton Scott A Antimicrobial articles and method of manufacture
WO2008065329A2 (en) * 2006-11-30 2008-06-05 Systagenix Wound Management Ip Co. B.V. Protein sheet material
WO2008065329A3 (en) * 2006-11-30 2009-01-08 Ethicon Inc Protein sheet material
US20080146983A1 (en) * 2006-12-19 2008-06-19 Biopol Co., Ltd. Polyurethane foam dressing with improved moisturization
US7777091B2 (en) * 2006-12-19 2010-08-17 Biopol Co., Ltd. Polyurethane foam dressing with improved moisturization
US20090128716A1 (en) * 2007-11-15 2009-05-21 Funai Electric Co., Ltd. Projector and method for projecting image
US20100143487A1 (en) * 2007-12-26 2010-06-10 Gel-Del Technologies, Inc. Biocompatible protein-based particles and methods thereof
US8039591B2 (en) 2008-04-23 2011-10-18 Codman & Shurtleff, Inc. Flowable collagen material for dural closure
US20090269413A1 (en) * 2008-04-23 2009-10-29 Codman & Shurtleff, Inc. Flowable collagen material for dural closure
US9205170B2 (en) 2008-05-02 2015-12-08 Hemcon Medical Technologies, Inc. Wound dressing devices and methods
US20100172958A1 (en) * 2008-05-02 2010-07-08 Hemcon Medical Technologies, Inc. Wound dressing devices and methods
DE202011100392U1 (en) 2011-05-07 2011-06-09 Neubauer, Norbert, 38820 Burns Edition
US9403953B2 (en) 2011-07-06 2016-08-02 Diversified Global Technologies, Llc Cosmetic sponge and method for providing a cosmetic sponge
US20150125512A1 (en) * 2012-03-13 2015-05-07 Aap Biomaterials Gmbh Antibacterial sheet material that can be used as a wound dressing and method for producing same
WO2013135478A1 (en) * 2012-03-13 2013-09-19 Aap Biomaterials Gmbh Antibacterial sheet material that can be used as a wound dressing and method for producing same
US9849611B2 (en) 2012-03-13 2017-12-26 Aap Biomaterials Gmbh Method for producing collagen-containing sheet material
US9089366B2 (en) 2013-04-04 2015-07-28 Steven Garner-Richards System for tracking surgical objects
US20160129151A1 (en) * 2014-11-06 2016-05-12 Case Western Reserve University Protein based materials

Similar Documents

Publication Publication Date Title
US3526224A (en) Dressing
Sheridan et al. Artificial skin in massive burns—results to ten years
Adekogbe et al. Fabrication and characterization of DTBP-crosslinked chitosan scaffolds for skin tissue engineering
Dai et al. Composite cell support membranes based on collagen and polycaprolactone for tissue engineering of skin
US5948429A (en) Methods for preparing biopolymer foams
US5532217A (en) Process for the mineralization of collagen fibers, product produced thereby and use thereof to repair bone
US6514286B1 (en) Biodegradable polymeric film
US4902565A (en) Water absorbent structures
US4655758A (en) Microbial polysaccharide articles and methods of production
Neel Implants of Gore-Tex: comparisons with Teflon-coated polytetrafluoroethylene carbon and porous polyethylene implants
US4661530A (en) Biocompatible, antithrombogenic materials suitable for reconstructive surgery
US5512301A (en) Collagen-containing sponges as drug delivery compositions for proteins
US4860737A (en) Wound dressing, manufacture and use
Schneider et al. Biofunctionalized electrospun silk mats as a topical bioactive dressing for accelerated wound healing
US6855860B2 (en) Composite dressings for the treatment of wounds
US5665114A (en) Tubular expanded polytetrafluoroethylene implantable prostheses
Miyata et al. Collagen engineering for biomaterial use
Wang et al. Chitosan‐alginate PEC membrane as a wound dressing: Assessment of incisional wound healing
Chang et al. A genipin-crosslinked gelatin membrane as wound-dressing material: in vitro and in vivo studies
Choi et al. Studies on gelatin-based sponges. Part III: a comparative study of cross-linked gelatin/alginate, gelatin/hyaluronate and chitosan/hyaluronate sponges and their application as a wound dressing in full-thickness skin defect of rat
Boyce et al. Structure of a collagen‐GAG dermal skin substitute optimized for cultured human epidermal keratinocytes
US4175557A (en) Polymeric sheets
US5556391A (en) Surgical sponge device
US5851461A (en) Method of producing polysaccharide foams
US4458678A (en) Cell-seeding procedures involving fibrous lattices